CONCANAMYCIN A

CONCANAMYCIN A Basic information
Product Name:CONCANAMYCIN A
Synonyms:CONCANAMYCIN A;CONCANAMYCIN A, STREPTOMYCES SP;concanamycin A from streptomyces species;A661-I;Antibiotic A661I;Antibiotic S-45A;S-45A;(3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[[4-O-(Aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyloxacyclooctadeca-3,5,13,15-tetraen-2-one
CAS:80890-47-7
MF:C46H75NO14
MW:866.09
EINECS:620-709-4
Product Categories:
Mol File:80890-47-7.mol
CONCANAMYCIN A Structure
CONCANAMYCIN A Chemical Properties
Melting point 179-180℃ (dichloromethane ethanol )
Boiling point 966.4±65.0 °C(Predicted)
density 1.20±0.1 g/cm3(Predicted)
storage temp. −20°C
solubility Soluble in DMSO
pka12.46±0.70(Predicted)
form Lyophilized solid
color White
BRN 3560277
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
Safety Information
Hazard Codes T+
Risk Statements 26/27/28-36
Safety Statements 26-36/37/39-45
RIDADR UN 3462 6.1/PG 2
WGK Germany 3
RTECS CB9732000
10-21
HazardClass 6.1(b)
PackingGroup III
HS Code 2941900000
MSDS Information
ProviderLanguage
SigmaAldrich English
CONCANAMYCIN A Usage And Synthesis
DescriptionConcanamycin A (80890-47-7) is a potent and specific inhibitor of the vacuolar (V-type) H+-ATPase which can induce apoptotic cell death in various cell lines.1,2?Inhibits cell surface expression of virus envelope glycoproteins.3?Dramatically increases the rate of extracellular vesicle release from a variety of cell types.4?Inhibits autophagy by blocking lysosomal acidification.5
UsesConcanamycin A is the major analogue of the concanamycin complex produced by Streptomyces sp.. It has been shown to act as a potent and specific vacuolar-ATPase inhibitor. Concanamycin A inhibits the acidification of organelles and blocks cell surface expression of viral envelope glycoproteins without affecting their synthesis. It also interferes with intracellular protein trafficking and inhibits perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. Concanamycins are structurally related to the bafilomycins.
UsesConcanamycin A has been used:
  • as a lysosomal inhibitor in young and old fibroblasts
  • as a vacuolar-type H+-ATPase inhibitor in presynaptic vesicles
  • as a lysosomal acidification blocker in HepG2 hepatocytes cells

DefinitionChEBI: A concanamycin in which the lactone ring contains 4 double bonds and is substituted by 4 methyl groups, 2 hydroxy groups, 2 methoxy groups and an ethyl group.
General DescriptionChemical structure: macrolide
Biological ActivitySpecific inhibitor of V-type (vacuolar) H + -ATPase that displays > 2000-fold selectivity over other H + -ATPases (IC 50 values are 9.2, > 20000, > 20000 and > 20000 nM for yeast V-type, F-type, P-type H + -ATPases and porcine P-type Na + ,K + -ATPase respectively). Blocks cell surface expression of virus envelope glycoproteins without affecting synthesis and exhibits cytotoxicity in several cell lines.
Biochem/physiol ActionsConcanamycin A (ConA) inhibits acidification of organelles and perforin-mediated cytotoxicity. It is a vacuolar-type v-ATPase inhibitor. ConA possesses antiprotozoal and antineoplastic properties. It mediates inhibition of the negative factor (Nef) protein of the human immunodeficiency virus.
storageStore at -20°C
References1) Nishihara?et al.?(1995),?Specific inhibitors if vacuolar type H(+)-ATPases induce apoptotic cell death; Biochem. Biophys, Res. Commun.,?212?255 2) Hong?et al. (2006),?Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells; J. Pharmacol. Exp. Ther.,?319?672 3) Muroi?et al.?(1993),?Folimycin (concanamycin A), a specific inhibitor of V-ATPase, blocks intracellular translocation of the glycoprotein of vesicular stomatitis virus before arrival to the Golgi apparatus; Cell Struct. Function,?18?139 4) Cashikar and Hanson (1987),?A cell-based assay for CD63-containing extracellular vesicles; PLoS One,?14?e0220007 5) Gradzka?et al.?(2018),?Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes; Cell Death Dis.,?9?529
CONCANAMYCIN A Preparation Products And Raw materials
Ethyl-2,4-decadienoate 2,4-DECADIENOIC ACID METHYL ESTER 2,4-NONADIEN-1-OL ISODECYL ACRYLATE hedonal (E,E)-2,4-Dodecadienal viranamycin B 2,4-UNDECADIEN-1-OL 2-methoxyethyl carbamate HYDROXYPROPYLCARBAMATE BUTYL SORBATE concanamycin D ETHYL SORBATE 2,4-DECADIEN-1-OL trans,trans-2,4-undecadienal concanamycin E 2-ethoxyethyl carbamate CONCANAMYCIN A

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.